Metaplasia in the Stomach—Precursor of Gastric Cancer?
AbstractDespite a significant decrease in the incidence of gastric cancer in Western countries over the past century, gastric cancer is still one of the leading causes of cancer-related deaths worldwide. Most human gastric cancers develop after long-term Helicobacter pylori infection via the Correa pathway: the progression is from gastritis, atrophy, intestinal metaplasia, dysplasia, to cancer. However, it remains unclear whether metaplasia is a direct precursor of gastric cancer or merely a marker of high cancer risk. Here, we review human studies on the relationship between metaplasia and cancer in the stomach, data from mouse models of metaplasia regarding the mechanism of metaplasia development, and the cellular responses induced by H. pylori infection. View Full-Text
Share & Cite This Article
Kinoshita, H.; Hayakawa, Y.; Koike, K. Metaplasia in the Stomach—Precursor of Gastric Cancer? Int. J. Mol. Sci. 2017, 18, 2063.
Kinoshita H, Hayakawa Y, Koike K. Metaplasia in the Stomach—Precursor of Gastric Cancer? International Journal of Molecular Sciences. 2017; 18(10):2063.Chicago/Turabian Style
Kinoshita, Hiroto; Hayakawa, Yoku; Koike, Kazuhiko. 2017. "Metaplasia in the Stomach—Precursor of Gastric Cancer?" Int. J. Mol. Sci. 18, no. 10: 2063.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.